
    
      To assess after 84 days, on a large scale patient population, the evaluation of ocular
      surface diseases and the satisfaction of dry eye disease (DED) treatment naïve patients or
      those who had to switch for tolerance, dissatisfaction or efficacy reasons to Thealoz® Duo.
    
  